
Please try another search
The Ensign Group, Inc. (NASDAQ:ENSG) recently completed the buyouts of the operations of two skilled nursing facilities located in Commerce City, CO. Subject to long-term, triple net leases, the transactions were effective Mar 1, 2020.
The addition of Ridgeview Post Acute, a skilled nursing facility with 105 skilled nursing beds, and Irondale Post Acute, a skilled nursing facility with 83 skilled nursing beds, adds 216 skilled nursing operations to the company’s portfolio. It also owns the real estate at 91 healthcare operations. This strategic move is in line with its commitment to serve the greater Denver healthcare market.
Management confirmed that the company is still looking to purchase real estate and lease both well-performing and struggling skilled nursing, assisted living and other healthcare-related businesses throughout the United States.
Acquisition Story
Ensign Group has been on an acquisition spree for skilled nursing facilities. It has a tradition of acquiring distressed healthcare operations that require significant clinical, financial and cultural turnaround. The company has a track record of closing 208 acquisitions in all over the period of 10 years (2009-2019).
The company is also adding value to its real estate portfolio by improving the operating results in its owned operations and acquiring additional real-estate assets.
Last year, the company successfully expanded its operation with the addition of 22 stand-alone skilled nursing operations, one stand-alone senior living operation and four campus operations. It also invested in new ancillary services that are complementary to its existing businesses.
Other Strategic Initiatives
Apart from buyouts, the company separated its home health and hospice business into a publicly-traded company. This spin-off is expected to meet not only patients' requirements but also be beneficial to its shareholders. The company hopes to add capabilities to its home health, senior living and hospice business line through this spin-off. We expect the divestiture to enable Ensign Group to focus on its core operations.
Price Performance
Shares of this Zacks Rank #1 (Strong Buy) company have lost 16.2% in a year’s time, wider than its industry’s decline of 12.8%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock price performance looks subdued when compared with the returns of other companies in the same space, such as Genesis Healthcare, Inc. (NYSE:GEN) and UnitedHealth Group Incorporated (NYSE:UNH) , which have gained 34.4% and 8.3%, respectively, and Brookdale Senior Living Inc. (NYSE:BKD) , which has decreased 7.1% in the past year.
However, we expect the company to fare better going forward on the back of its solid fundamentals like inorganic growth and the improving top line.
Through many years of frustration among gold bugs due to the failure of gold stock prices to leverage the gold prices in a positive way, there were very clear reasons for that...
I know there is the smell of fear in the air when I see my readership double as we reach a point where weekly chart factors come into play. Up until last week, markets have...
• Trump’s trade war, inflation data, and last batch of earnings will be in focus this week. • DoorDash’s imminent inclusion in the S&P 500 is likely to trigger a wave of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.